Semaglutide and Heart Rate: What the Evidence Actually Shows

Step 1: Understanding why semaglutide affects heart rate at all

Semaglutide works by activating GLP-1 receptors, which are found not just in the gut and brain but also in the heart and blood vessels. This is partly why the medicine has broader cardiovascular effects beyond weight loss. The modest rise in resting heart rate observed in trials is thought to be a direct result of this receptor activity, independent of the weight you lose or the nausea you might feel early on.

The STEP 1 trial, published in the New England Journal of Medicine, which studied semaglutide 2.4mg over 68 weeks in adults with obesity, reported a mean increase in resting pulse of around two to three beats per minute compared with placebo. That figure sits comfortably within a normal day-to-day variation for most people. It is not zero, but it is not alarming either, which is why understanding the nuance matters more than a headline number.

It helps to think of it this way: your heart rate already shifts by ten or twenty beats per minute depending on whether you had a coffee or walked up the stairs. A two-beat rise from semaglutide is genuinely small in that context. Still, small averages mask individual variation, and a minority of people do notice a more pronounced change. You can read more about what drives that variation on our page about semaglutide's effect on resting heart rate.

Step 2: Recognising what is likely treatment-related and what needs checking

For most people on semaglutide, the heart rate change is silent, you will not feel it unless you are measuring. The situations that warrant attention are different, and they fall into a few clear patterns.

First, a persistently elevated resting heart rate above 100 beats per minute (tachycardia) is worth reporting to your prescriber, even if you feel fine. Second, if you notice your heart beating very fast, skipping beats, or feeling irregular, do not attribute it automatically to semaglutide and wait. Palpitations can have many causes, and a clinician needs to distinguish between a benign treatment effect and something that requires investigation.

Third, and this is the scenario that catches people out: GI side effects like nausea, vomiting, or diarrhoea can lead to dehydration, and dehydration itself raises heart rate. So what feels like a semaglutide heart rate effect might partly be your body signalling it needs more fluids. The NHS's patient information on semaglutide flags dehydration as a risk to watch for, especially early in treatment.

If you are tracking your pulse with a smartwatch and your resting heart rate is creeping up week on week rather than settling, mention it at your next clinical check-in. At nume, aftercare runs seven days a week precisely because these are the sorts of questions that should not wait until your next scheduled review.

Step 3: Specific situations where heart rate deserves extra attention

People with a history of tachycardia, arrhythmia, or heart failure should discuss semaglutide's cardiovascular profile carefully with a prescriber before starting, not because semaglutide is necessarily unsuitable, but because the baseline picture matters. The medicine's GLP-1 activity has actually shown cardiovascular benefit in trial populations at high risk, reducing major cardiac events, but that is a population-level finding and individual assessment still applies.

Those taking beta-blockers or other medicines that slow the heart should be aware of the interaction not because semaglutide dramatically counteracts these drugs, but because a prescriber will want the complete picture. The same applies if you are taking other medicines that affect rhythm. If semaglutide and heart health as a broader topic is relevant to your situation, our overview of semaglutide and heart health covers the evidence in more depth.

Pregnancy is a separate consideration entirely. Semaglutide is not recommended during pregnancy, and women of childbearing age should discuss contraception with their prescriber, there is more on this on our Wegovy and pregnancy page. There is also a question of whether the heart rate rise persists long-term: current evidence suggests it tends to plateau rather than increase progressively with continued treatment.

Step 4: Monitoring practically and knowing when to act

You do not need a medical-grade monitor. Most people manage fine by checking their pulse manually for 60 seconds, first thing in the morning before getting out of bed. Do it a few times in the week before starting treatment so you have a genuine baseline, the sort of thing you might do before the kettle goes on. Then check again at around the four-week mark.

A two-to-five-beat rise from your baseline is within the expected range and does not require action beyond noting it. A rise of fifteen or more beats from your personal baseline, or a new sensation of palpitations, fast heartbeat, or dizziness, is worth contacting your clinical team about promptly. The Yellow Card scheme at yellowcard.mhra.gov.uk also allows you to report suspected side effects directly to the MHRA, and doing so contributes to ongoing safety monitoring of medicines like semaglutide.

If you are weighing up whether semaglutide is the right option given your cardiovascular history, you can read about how Wegovy compares more broadly on the Wegovy overview page. And if cost is part of the decision, our Wegovy price page lays out what private treatment typically involves transparently, with no hidden fees.

When you are ready to talk it through with a clinician, check your eligibility with our prescribers, your full health history, including any cardiovascular concerns, is exactly what the consultation is designed to assess.